5B2-20256-08909 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-03
Dose 1 — Pfizer-BioNTech
2021-06-28
Dose 2 — Pfizer-BioNTech
2022-01-25
Registered in v-safe
2022-01-25
Dose 3 — Pfizer-BioNTech
2022-01-25
Health check-in — day 0, dose 3
Feeling: Fair · Fatigue or tiredness

Adult check-in
2022-01-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache, Nausea

Adult check-in
2022-01-27
Survey response — days 1–6 daily, dose 3
MedDRA: Vomiting — Feeling: Fair · Headache, Nausea

Free text: Threw up once

MedDRA releases: 2024-11 · check-in free text available
2022-01-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2022-02-17
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-03	Pfizer-BioNTech	No
2	2021-06-28	Pfizer-BioNTech	No
3	2022-01-25	Pfizer-BioNTech	No

Free text

Release 11 — days 1–6 daily, dose 3

2022-01-27

Systemic reaction (other): Threw up once

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Vomiting	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release